Cargando…

Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening acute inflammatory vesiculobullous reactions of the skin and mucous membranes. These severe cutaneous drug reactions are known to be caused by inciting drugs and infectious agents. Previously, we have reported t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakatani, Ken, Ueta, Mayumi, Khor, Seik-Soon, Hitomi, Yuki, Okudaira, Yuko, Masuya, Anri, Wada, Yuki, Sotozono, Chie, Kinoshita, Shigeru, Inoko, Hidetoshi, Tokunaga, Katsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838058/
https://www.ncbi.nlm.nih.gov/pubmed/31700100
http://dx.doi.org/10.1038/s41598-019-52619-2
_version_ 1783467146395779072
author Nakatani, Ken
Ueta, Mayumi
Khor, Seik-Soon
Hitomi, Yuki
Okudaira, Yuko
Masuya, Anri
Wada, Yuki
Sotozono, Chie
Kinoshita, Shigeru
Inoko, Hidetoshi
Tokunaga, Katsushi
author_facet Nakatani, Ken
Ueta, Mayumi
Khor, Seik-Soon
Hitomi, Yuki
Okudaira, Yuko
Masuya, Anri
Wada, Yuki
Sotozono, Chie
Kinoshita, Shigeru
Inoko, Hidetoshi
Tokunaga, Katsushi
author_sort Nakatani, Ken
collection PubMed
description Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening acute inflammatory vesiculobullous reactions of the skin and mucous membranes. These severe cutaneous drug reactions are known to be caused by inciting drugs and infectious agents. Previously, we have reported the association of HLA-A*02:06 and HLA-B*44:03 with cold medicine (CM)-related SJS/TEN with severe ocular complications (SOCs) in the Japanese population. However, the conventional HLA typing method (PCR-SSOP) sometimes has ambiguity in the final HLA allele determination. In this study, we performed HLA-disease association studies in CM-SJS/TEN with SOCs at 3- or 4-field level. 120 CM-SJS/TEN patients with SOCs and 817 Japanese healthy controls are HLA genotyped using the high-resolution next-generation sequencing (NGS)-based HLA typing of HLA class I genes, including HLA-A, HLA-B, and HLA-C. Among the alleles of HLA class I genes, HLA-A*02:06:01 was strongly associated with susceptibility to CM-SJS/TEN (p = 1.15 × 10(−18), odds ratio = 5.46). Four other alleles (HLA-A*24:02:01, HLA-B*52:01:01, HLA-B*46:01:01, and HLA-C*12:02:02) also demonstrated significant associations. HLA haplotype analyses indicated that HLA-A*02:06:01 is primarily associated with susceptibility to CM-SJS/TEN with SOCs. Notably, there were no specific disease-causing rare variants among the high-risk HLA alleles. This study highlights the importance of higher resolution HLA typing in the study of disease susceptibility, which may help to elucidate the pathogenesis of CM-SJS/TEN with SOCs.
format Online
Article
Text
id pubmed-6838058
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68380582019-11-14 Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing Nakatani, Ken Ueta, Mayumi Khor, Seik-Soon Hitomi, Yuki Okudaira, Yuko Masuya, Anri Wada, Yuki Sotozono, Chie Kinoshita, Shigeru Inoko, Hidetoshi Tokunaga, Katsushi Sci Rep Article Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening acute inflammatory vesiculobullous reactions of the skin and mucous membranes. These severe cutaneous drug reactions are known to be caused by inciting drugs and infectious agents. Previously, we have reported the association of HLA-A*02:06 and HLA-B*44:03 with cold medicine (CM)-related SJS/TEN with severe ocular complications (SOCs) in the Japanese population. However, the conventional HLA typing method (PCR-SSOP) sometimes has ambiguity in the final HLA allele determination. In this study, we performed HLA-disease association studies in CM-SJS/TEN with SOCs at 3- or 4-field level. 120 CM-SJS/TEN patients with SOCs and 817 Japanese healthy controls are HLA genotyped using the high-resolution next-generation sequencing (NGS)-based HLA typing of HLA class I genes, including HLA-A, HLA-B, and HLA-C. Among the alleles of HLA class I genes, HLA-A*02:06:01 was strongly associated with susceptibility to CM-SJS/TEN (p = 1.15 × 10(−18), odds ratio = 5.46). Four other alleles (HLA-A*24:02:01, HLA-B*52:01:01, HLA-B*46:01:01, and HLA-C*12:02:02) also demonstrated significant associations. HLA haplotype analyses indicated that HLA-A*02:06:01 is primarily associated with susceptibility to CM-SJS/TEN with SOCs. Notably, there were no specific disease-causing rare variants among the high-risk HLA alleles. This study highlights the importance of higher resolution HLA typing in the study of disease susceptibility, which may help to elucidate the pathogenesis of CM-SJS/TEN with SOCs. Nature Publishing Group UK 2019-11-07 /pmc/articles/PMC6838058/ /pubmed/31700100 http://dx.doi.org/10.1038/s41598-019-52619-2 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Nakatani, Ken
Ueta, Mayumi
Khor, Seik-Soon
Hitomi, Yuki
Okudaira, Yuko
Masuya, Anri
Wada, Yuki
Sotozono, Chie
Kinoshita, Shigeru
Inoko, Hidetoshi
Tokunaga, Katsushi
Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing
title Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing
title_full Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing
title_fullStr Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing
title_full_unstemmed Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing
title_short Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing
title_sort identification of hla-a*02:06:01 as the primary disease susceptibility hla allele in cold medicine-related stevens-johnson syndrome with severe ocular complications by high-resolution ngs-based hla typing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6838058/
https://www.ncbi.nlm.nih.gov/pubmed/31700100
http://dx.doi.org/10.1038/s41598-019-52619-2
work_keys_str_mv AT nakataniken identificationofhlaa020601astheprimarydiseasesusceptibilityhlaalleleincoldmedicinerelatedstevensjohnsonsyndromewithsevereocularcomplicationsbyhighresolutionngsbasedhlatyping
AT uetamayumi identificationofhlaa020601astheprimarydiseasesusceptibilityhlaalleleincoldmedicinerelatedstevensjohnsonsyndromewithsevereocularcomplicationsbyhighresolutionngsbasedhlatyping
AT khorseiksoon identificationofhlaa020601astheprimarydiseasesusceptibilityhlaalleleincoldmedicinerelatedstevensjohnsonsyndromewithsevereocularcomplicationsbyhighresolutionngsbasedhlatyping
AT hitomiyuki identificationofhlaa020601astheprimarydiseasesusceptibilityhlaalleleincoldmedicinerelatedstevensjohnsonsyndromewithsevereocularcomplicationsbyhighresolutionngsbasedhlatyping
AT okudairayuko identificationofhlaa020601astheprimarydiseasesusceptibilityhlaalleleincoldmedicinerelatedstevensjohnsonsyndromewithsevereocularcomplicationsbyhighresolutionngsbasedhlatyping
AT masuyaanri identificationofhlaa020601astheprimarydiseasesusceptibilityhlaalleleincoldmedicinerelatedstevensjohnsonsyndromewithsevereocularcomplicationsbyhighresolutionngsbasedhlatyping
AT wadayuki identificationofhlaa020601astheprimarydiseasesusceptibilityhlaalleleincoldmedicinerelatedstevensjohnsonsyndromewithsevereocularcomplicationsbyhighresolutionngsbasedhlatyping
AT sotozonochie identificationofhlaa020601astheprimarydiseasesusceptibilityhlaalleleincoldmedicinerelatedstevensjohnsonsyndromewithsevereocularcomplicationsbyhighresolutionngsbasedhlatyping
AT kinoshitashigeru identificationofhlaa020601astheprimarydiseasesusceptibilityhlaalleleincoldmedicinerelatedstevensjohnsonsyndromewithsevereocularcomplicationsbyhighresolutionngsbasedhlatyping
AT inokohidetoshi identificationofhlaa020601astheprimarydiseasesusceptibilityhlaalleleincoldmedicinerelatedstevensjohnsonsyndromewithsevereocularcomplicationsbyhighresolutionngsbasedhlatyping
AT tokunagakatsushi identificationofhlaa020601astheprimarydiseasesusceptibilityhlaalleleincoldmedicinerelatedstevensjohnsonsyndromewithsevereocularcomplicationsbyhighresolutionngsbasedhlatyping